Qube Research & Technologies (QRT)’s Aquestive Therapeutics AQST Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AQST Stock Details AQST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-140,889	Closed	-$502K	–	3471
2024 Q4	$502K	Sell	140,889 -141,542	-50%	-$653K	﹤0.01%	2475
2024 Q3	$1.41M	Sell	282,431 -435,669	-61%	-$1.7M	﹤0.01%	1904
2024 Q2	$1.87M	Sell	718,100 -131,113	-15%	-$438K	﹤0.01%	1658
2024 Q1	$3.62M	Buy	849,213 +782,666	+1,176%	+$2.61M	0.01%	1411
2023 Q4	$134K	Buy	66,547 +66,541	+1,109,017%	+$118K	﹤0.01%	2986
2023 Q3	$9	Buy	+6	New	+$10	﹤0.01%	3931
2020 Q2	–	Sell	-13,974	Closed	-$31K	–	1696
2020 Q1	$31K	Sell	13,974 -21,501	-61%	-$81.7K	﹤0.01%	1033
2019 Q4	$206K	Buy	+35,475	New	+$185K	0.01%	1379

Other funds holding AQST

BCM

Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

Qube Research & Technologies (QRT)'s AQST Position: Q1 2025 in Review

Qube Research & Technologies (QRT) sold out of Aquestive Therapeutics (AQST) in Q1 2025, closing a stake of 140,889 shares — an estimated $502K sold.

Qube Research & Technologies (QRT) first reported a position in AQST in Q4 2019 and held it in 8 quarters. The position peaked at $3.62M in Q1 2024. 121 funds tracked by Wall St. Rank hold AQST as of Q1 2025.

Qube Research & Technologies (QRT) reported no remaining Aquestive Therapeutics position as of Q1 2025 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 140,889 Aquestive Therapeutics shares in Q1 2025, an estimated $502K.
Qube Research & Technologies (QRT) first reported a position in Aquestive Therapeutics in Q4 2019 and held it in 8 quarters.
Qube Research & Technologies (QRT)'s Aquestive Therapeutics position peaked at $3.62M in Q1 2024.
121 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2025, filed 15 May 2025.